Asasantin Retard 200mg / 25mg Modified Release Hard Capsules
- Licence status
- Withdrawn: 01/09/2020
- Active substances
- Aspirin, Dipyridamole
- Dosage Form
- Capsules Modified Release
- Licence number
- PPA1151/128/001
- Licence holder
- Imbat Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- B01AC Platelet aggregation inhibitors excl. heparin, B01AC30 combinations
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 27/11/2009